Skip to main content
. 2018 Oct 9;33(1):1575–1580. doi: 10.1080/14756366.2018.1515933

Figure 1.

Figure 1.

Clinically used triazene substituted compounds (TMZ and DTIC) and efficient CAI SLC-0111 (phase I/II trials for the advanced metastatic solid tumours).